Key Insights

Highlights

Treatment Research

4 treatments under study, led by Ivermectin W Albendazole

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Active Not Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT06070116Phase 2Active Not Recruiting

Safety and Efficacy of Novel Combination Regimens for Treatment of Onchocerciasis

Showing all 1 trials

Research Network

Common Treatments

  • Ivermectin W Albendazole1
  • Moxidectin Albendazole1
  • Moxidectin Diethylcarbamazine Albendazole1
  • Ivermectin Diethylcarbamazine Albendazole1

Active Sponsors

  • Washington University School of Medicine1
  • National Public Health Institute of Liberia1

Top Investigators

Related Conditions

  • Onchocerciasis1
  • Tropical Disease1
  • Onchocerciasis Ocular1
  • Onchocercal Subcutaneous Nodule1

Activity Timeline